Project Number GC-201801-2014580 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2018 View Full Project Details for A pilot pharmacodynamic study of Anti-SEMA4D Antibody (VX15) in early Alzheimer’s disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator Siemers, Eric Principal Investigator First Name Eric Principal Investigator Last Name Siemers Awardee Organization Vaccinex Inc. Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement Program to Accelerate Clinical Trials (PACT) RFP FY Overall Cost $2,992,766 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
